Aardvark Therapeutics - Rasio total nilai perusahaan marang pendapatan AARD

Logo perusahaan publik aardvarktherapeutics.com (AARD)

Patent protection for TAS2R agonists and strict FDA regulations create a robust barrier to entry for competitors. The current enterprise value-to-revenue ratio confirms this resilience, with the metric standing at 0.00. Aardvark Therapeutics Inc (AARD) bases its growth foundation on R&D in intestinal receptors, while the high value of therapies for rare pathologies allows the company to exercise pricing power and set premium prices for its products.

AARD Aardvark Therapeutics Inc: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Aardvark Therapeutics Inc. - rincian analitis lan metrik utama (AARD)

- informasi babagan dhuwit lan arus kas:
Analisis wiwitan perusahaan:Aardvark Therapeutics Inc AARD
Produk seri Aardvark Therapeutics

For Aardvark Therapeutics Inc (AARD), which utilizes outsourced small molecule production, this metric assesses capitalization efficiency excluding debt load. The indicator sums the market value of shares and net debt, dividing the result by sales volume. The current value of 0.00 for the Enterprise Value to Sales ratio reflects market expectations for future revenues. The Enterprise Value to Sales trend filters out short-term liquidity fluctuations. Excessive growth in this ratio signals that assets are overvalued.

Analisis pesaing Aardvark Therapeutics Inc

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)